Kisspeptin-10 Structure: The KISS1R Decapeptide Explained

Some signaling molecules are sprawling proteins. Kisspeptin-10 is the opposite — just ten amino acids, supplied strictly for research use only, yet it carries nearly all the information its receptor needs to recognize it. If you are studying this compound, the kisspeptin-10 structure is the right place to start. The sequence, where the molecule comes from, and the receptor it was shaped to fit explain almost everything else researchers find interesting about it. This article walks through each of those pieces in plain language, then connects them back to why the molecule behaves the way it does in laboratory studies.

The Decapeptide Sequence, Residue by Residue

Kisspeptin-10 is a decapeptide — a chain of exactly ten amino acids. Written in single-letter code, that chain is YNWNSFGLRF-NH₂. Spelled out, the residues run tyrosine (Y), asparagine (N), tryptophan (W), asparagine (N), serine (S), phenylalanine (F), glycine (G), leucine (L), arginine (R), and a final phenylalanine (F).

That "-NH₂" on the end is not a typo or an afterthought. It signals that the molecule's C-terminus is amidated — the usual terminal carboxyl group has been converted to an amide. As we will see, that small chemical detail turns out to be one of the most important things about the whole molecule.

Among the naturally occurring kisspeptins, this ten-residue version is the shortest fragment that still binds and activates the receptor with meaningful potency. Structure-activity work shows the activity sits toward the back end of the chain: the five C-terminal residues, and the final phenylalanine in particular, are the ones the receptor actually reads (structure-activity study, PMC). Knowing the kisspeptin-10 amino acid sequence, then, is really about knowing which end matters.

From the KISS1 Precursor to a Family of Peptides

Here is the first thing to understand: kisspeptin-10 is never built on its own inside a cell. It is a fragment cut from a longer precursor, the same way several other research peptides are.

That precursor is the product of the KISS1 gene — a 145-amino-acid protein. Cellular processing trims it down into a small family of shorter peptides that all end in the same tail: a 54-residue form (historically called metastin, or KP-54), plus KP-14, KP-13, and the KP-10 we are focused on here (nomenclature review, PMC). The longer forms vary more from species to species. The final ten residues are highly conserved — a strong clue that this is the part doing the essential work.

The naming itself has a tangled history worth knowing if you read older papers. These peptides settled into the "KP-" convention only after years of mixed terminology, and the receptor went through even more names — AXOR12, hOT7T175, GPR54 — before the field landed on KISS1R. Compare the KISS1 precursor literature across decades and you will meet the same molecules under several aliases.

The RFamide C-Terminus: Why the Tail Does the Work

Look again at the last two residues: arginine (R) followed by an amidated phenylalanine (F-NH₂). That arginine-phenylalanine-amide pairing has a name — the RF-amide motif — and it is the family signature kisspeptins share with several other signaling peptides, including prolactin-releasing peptide and the gonadotropin-inhibitory peptide.

So why does it matter so much? Because the amide cap is part of what the receptor recognizes. The C-terminal decapeptide is the segment required for binding to KISS1R, and the amidation is not optional decoration — it is structurally tied to activation (KISS1R system review, PMC). For the underlying picture of how that terminal group is formed, it is worth reviewing the chemistry of the C-terminal amide on its own.

This is the central idea of the kisspeptin-10 structure. The molecule is short, but it is not generic. The RFamide tail concentrates the recognition information into the last few residues, which is exactly why a ten-residue fragment can stand in for the full 54-residue parent.

Secondary Structure: The Short Helix at the Business End

A peptide only ten residues long is mostly flexible — there simply isn't enough chain to fold into anything elaborate. But flexible does not mean shapeless. When researchers examined kisspeptin-10 by NMR, they found ordered structure right where it counts.

The molecule adopts a helicoidal conformation toward its C-terminus, with mixed alpha-helix and 3₁₀-helix character (structural conformation study, PubMed). That short helix works as a scaffold, holding the key residues in the arrangement the receptor expects. It is a clean example of how a peptide's shape shapes its function — the parts that fold are the parts that matter.

Alanine-scanning — swapping one residue at a time for alanine and watching what breaks — points to positions 6 and 10 as critical. Replace the residue at the very C-terminus and the helix collapses in that region, abolishing activity in research models; changes near position 6 destabilize the helix more locally. The pattern is consistent: disturb the C-terminal shape, and the molecule stops being recognized.

Meeting the Receptor: KISS1R (GPR54)

Structure only means something in relation to what a molecule binds. For kisspeptin-10, that partner is KISS1R, the receptor formerly known as GPR54.

KISS1R is a 398-amino-acid, seven-transmembrane G-protein-coupled receptor, and it sits within the wider family of peptide-binding GPCRs. Its sequence is strongly conserved across vertebrates, especially in several of the transmembrane segments — another sign that the receptor and its decapeptide ligand evolved as a tightly matched pair.

What happens when the two meet? In cell-culture and animal-model research, binding of the kisspeptin C-terminus activates the receptor's Gq/11 pathway: phospholipase C switches on, which generates inositol trisphosphate and mobilizes intracellular calcium, and downstream the receptor selectively engages Erk1/2 signaling rather than every available kinase (KISS1R system review, PMC; kisspeptin overview). All of that is an observation from research systems, not a statement about outcomes in people — the compound is a research material, full stop.

Structure, Stability, and What Researchers Study Next

Structure also explains one of kisspeptin-10's well-documented limits: it does not last long in circulation. The same short, exposed chain that makes it easy to synthesize also makes it easy for enzymes to clip.

Structure-activity work points to the tyrosine at position 1 as a likely cleavage site, and researchers have explored conformation-stabilizing changes to slow that breakdown. One studied analog, [dY]1KP-10, swaps in a D-form tyrosine at that first position; in research models it actually binds the receptor a little less tightly yet shows altered in-vivo behavior, which investigators attribute to better metabolic stability rather than better binding (analog study, PMC).

That is a structure story at its core: change the molecule's shape at one position, and you change how long it survives — independent of how well it fits the receptor. It is also why "what is the kisspeptin-10 structure" and "why do researchers keep redesigning it" turn out to be the same question.

Frequently Asked Questions

What is the amino acid sequence of kisspeptin-10?

Kisspeptin-10 is the decapeptide YNWNSFGLRF-NH₂ — tyrosine, asparagine, tryptophan, asparagine, serine, phenylalanine, glycine, leucine, arginine, phenylalanine, ending in a C-terminal amide. It is the conserved final ten residues shared by all the larger kisspeptins.

Why does kisspeptin-10 end in "-NH₂"?

The "-NH₂" marks C-terminal amidation: the final carboxyl group is replaced by an amide. Research shows this amidated arginine-phenylalanine (RF-amide) tail is essential for binding and activating the KISS1R receptor, which is why every active kisspeptin carries it.

How is kisspeptin-10 related to kisspeptin-54?

Both come from the same 145-amino-acid KISS1 precursor. Kisspeptin-54 (metastin) is the longer processed form; kisspeptin-10 is its conserved C-terminal ten residues. In research, KP-10 binds KISS1R with affinity comparable to KP-54, because the receptor-recognition information sits in that shared tail.

What is KISS1R and what was it called before?

KISS1R is the G-protein-coupled receptor that kisspeptins bind. It was formerly known as GPR54, and earlier still as AXOR12 and hOT7T175 in different labs, before the field standardized on KISS1R. It is a 398-residue, seven-transmembrane receptor highly conserved across vertebrates.

Which parts of the kisspeptin-10 structure matter most?

Structure-activity research points to the five C-terminal residues — especially phenylalanine at position 6 and the arginine-phenylalanine-amide at positions 9-10 — plus the short C-terminal helix seen by NMR. Disrupting that C-terminal region in research models abolishes receptor activity.

Conclusion

Kisspeptin-10 is a small molecule with a tidy story. It is a ten-residue RFamide decapeptide, YNWNSFGLRF-NH₂, cut from the larger KISS1 precursor; its activity lives in an amidated C-terminal tail braced by a short helix; and it is recognized by KISS1R, a seven-transmembrane GPCR once called GPR54. Once you can see how those pieces fit, the rest of the literature — the analogs, the stability tweaks, the receptor signaling — reads as variations on a single structural theme. For researchers comparing compounds, that structural foundation is the place to build from, and the related explainers linked above are good next stops.

For research use only. Not for human or animal consumption of any kind. The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The statements made have not been evaluated by the U.S. Food and Drug Administration. These products are NOT FDA APPROVED. Please consult with a licensed healthcare professional before making any decisions regarding your health or research.

Optides LLC is a chemical supplier. Optides LLC is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.